Search results for "Infectious diseases"
CBT improved severe fatigue after COVID-19, Dutch trial finds
After randomization, patients with severe fatigue three to 12 months after COVID-19 infection benefited from cognitive behavioral therapy (CBT) compared to usual care.
https://immattersacp.org/weekly/archives/2023/05/16/2.htm
16 May 2023
IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir
The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://immattersacp.org/weekly/archives/2022/05/17/2.htm
17 May 2022
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum X: Current Clinical Challenges in COVID-19 Prevention and Management
During the Sept. 7 virtual live event, a panel of experts will discuss current methods for preventing and managing SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/08/30/4.htm
30 Aug 2022
Long-acting treatments may play a role in eradication of HCV
A cross-sectional survey of patients with or at risk for hepatitis C virus (HCV) found a high acceptability of long-acting treatments such as injections or implants, although daily oral medications were preferred by most. The authors noted that long-acting treatments might contribute to global efforts to eliminate HCV infection.
https://immattersacp.org/weekly/archives/2021/11/02/4.htm
2 Nov 2021
CDC study shows uptick in C. auris infections in recent years
Cases and transmission of Candida auris have continued to rise since the multidrug-resistant fungus was first reported in the U.S. in 2016. Reports of cases to the CDC rose by 44% in 2019 and 95% in 2021.
https://immattersacp.org/weekly/archives/2023/03/21/1.htm
21 Mar 2023
Monkeypox: 5 key points
An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022
Guideline addresses viral testing in patients with community-acquired pneumonia
The new American Thoracic Society guideline opposes routine use of nucleic acid-based testing for noninfluenza viral pathogens in outpatients with community-acquired pneumonia but identifies some uses for the tests in inpatients.
https://immattersacp.org/weekly/archives/2021/05/11/4.htm
11 May 2021
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Interim data find vaccine 66% to 85% effective against symptomatic RSV in older adults
The results from a large ongoing phase 3 trial show success in protection from respiratory syncytial virus (RSV)-associated lower respiratory tract illness on two important primary endpoints, although reductions in hospitalization and death have yet to be shown.
https://immattersacp.org/weekly/archives/2023/04/11/1.htm
11 Apr 2023